We are live on ! Find out more
FCE

Fiera Capital (Europe) Portfolio holdings

AUM $213M
1-Year Est. Return 42.35%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+42.35%
3 Year Est. Return
+41.33%
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
-$6.16M
Cap. Flow
-$13.8M
Cap. Flow %
-10.98%
Top 10 Hldgs %
76.69%
Holding
63
New
10
Increased
21
Reduced
12
Closed
6

Top Buys

Rank Stock Value
1
JD icon
JD.com
JD
+$3.78M
2
TAL icon
TAL Education Group
TAL
+$3.14M
3
UGP icon
Ultrapar
UGP
+$2.21M
4
PBR.A icon
Petrobras Class A
PBR.A
+$1.1M
5
BBD icon
Banco Bradesco
BBD
+$1.07M

Sector Composition

Rank Sector Weight
1 Financials 24.67%
2 Consumer Staples 24.25%
3 Communication Services 22.05%
4 Energy 10.54%
5 Industrials 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OREX
26
DELISTED
Orexigen Therapeutics, Inc.
OREX
$217K 0.17%
3,520
+690
+24% +$40.1K
BMY icon
27
Bristol-Myers Squibb
BMY
$132B
$214K 0.17%
4,427
+605
+16% +$29.8K
VTRS icon
28
Viatris
VTRS
$18.9B
$209K 0.17%
4,080
+595
+17% +$29.2K
PODD icon
29
Insulet
PODD
$9.79B
$193K 0.15%
4,868
TMO icon
30
Thermo Fisher Scientific
TMO
$220B
$191K 0.15%
1,622
+336
+26% +$39.5K
MDVN
31
DELISTED
MEDIVATION, INC.
MDVN
$176K 0.14%
4,588
MDT icon
32
Medtronic
MDT
$112B
$173K 0.14%
2,718
FRX
33
DELISTED
FOREST LABORATORIES INC
FRX
$167K 0.13%
1,685
+416
+33% +$38.8K
SNY icon
34
Sanofi
SNY
$104B
$143K 0.11%
2,700
INVA icon
35
Innoviva
INVA
$1.48B
$135K 0.11%
4,532
-869
-16% -$20.8K
TBPH icon
36
Theravance Biopharma
TBPH
$877M
$135K 0.11%
+4,340
New +$131K
AMGN icon
37
Amgen
AMGN
$222B
$126K 0.1%
1,065
BDX icon
38
Becton Dickinson
BDX
$48.2B
$124K 0.1%
1,076
+362
+51% +$41K
ILMN icon
39
Illumina
ILMN
$28.4B
$121K 0.1%
701
-278
-28% -$41.5K
ABT icon
40
Abbott
ABT
$187B
$117K 0.09%
2,855
+915
+47% +$35.9K
IPXL
41
DELISTED
Impax Laboratories, Inc.
IPXL
$86K 0.07%
+2,865
New +$77.3K
PCYC
42
DELISTED
PHARMACYCLICS INC
PCYC
$84K 0.07%
937
+418
+81% +$39.2K
SLXP
43
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$84K 0.07%
681
-387
-36% -$42.8K
BSX icon
44
Boston Scientific
BSX
$71.5B
$77K 0.06%
+6,060
New +$78.8K
BIIB icon
45
Biogen
BIIB
$30.7B
$74K 0.06%
236
NPSP
46
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$62K 0.05%
1,876
NSTG
47
DELISTED
NanoString Technologies, Inc.
NSTG
$61K 0.05%
4,081
CELG
48
DELISTED
Celgene Corp
CELG
$60K 0.05%
696
IQV icon
49
IQVIA
IQV
$39.3B
$52K 0.04%
973
INCY icon
50
Incyte
INCY
$24.4B
$43K 0.03%
+769
New +$39.3K

Similar funds

Fiera Capital (Europe)'s Q2 2014 Portfolio in Review

As of Q2 2014, Fiera Capital (Europe) held 63 positions worth $126M, down 4.7% from $132M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Fiera Capital (Europe) withdrew a net $13.8M in Q2 2014, closing 6 positions and reducing 12 holdings. Its most notable exit was CTC MEDIA INC COM STK, an estimated $7.89M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 22% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, Fiera Capital (Europe) opened a new position in JD.com worth $4.13M.

  • Fiera Capital (Europe)'s largest Q2 2014 buy was JD.com: 145,141 shares worth $4.13M.
  • Fiera Capital (Europe) added most to Petrobras Class A in Q2 2014, an estimated $1.1M increase.
  • Fiera Capital (Europe)'s biggest Q2 2014 reduction was Vale, cutting an estimated $6.47M.
  • Fiera Capital (Europe) fully exited CTC MEDIA INC COM STK in Q2 2014, selling an estimated $7.89M.
  • Fiera Capital (Europe)'s ten largest holdings make up 77% of its $126M portfolio in Q2 2014.
  • Fiera Capital (Europe) opened 10 new positions and closed 6 in Q2 2014.
  • Fiera Capital (Europe)'s portfolio value fell 4.7% quarter-over-quarter to $126M.

Based on Fiera Capital (Europe)'s 13F filing for Q2 2014, filed 11 Aug 2014.